Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages

Inflammation Research

Volumn 58, Issue 5, 2009, Pages 257-262

  Lee, S H ^a   Kim, J Y ^a   Seo, G S ^a   Kim, Y C ^a   Sohn, D H ^a  

^a Wonkwang University   (South Korea)

Author keywords

Extracellular signal regulated kinase1 2; Heme oxygenase 1; Isoliquiritigenin; Nitric oxide; Tumor necrosis factor

Indexed keywords

HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; ISOLIQUIRITIGENIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DALBERGIA; DALBERGIA ODORIFERA; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHALCONES; DALBERGIA; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 65549152471     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-8183-6     Document Type: Article

References (28)

1. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988; 2: 2557-68.
2. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008; 60: 79-127.
3. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006; 86: 583-650.
4. Kwak HJ, Song JS, No ZS, Song JH, Yang SD, Cheon HG. The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res. 2005; 54: 508-13.
5. Fürst R, Blumenthal SB, Kiemer AK, Zahler S, Vollmar AM. Nuclear factor-kappa B-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the c-jun N-terminal kinase/activator protein-1 pathway. J Pharmacol Exp Ther. 2006; 318: 389-94.
6. Helmer KS, Suliburk JW, Mercer DW. Ketamine-induced gastro-protection during endotoxemia: role of heme-oxygenase-1. Dig Dis Sci. 2006; 51: 1571-81.
7. Gonçalves GM, Cenedeze MA, Feitoza CQ, Wang PM, Bertocchi AP, Damião MJ, Pinheiro HS, Antunes Teixeira VP, dos Reis MA, Pacheco-Silva A, Câmara NO. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int. 2006; 70: 1742-9.
8. Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D, Luft FC, Haller H. Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol. 2007; 170: 1192-9.
9. Chan SC, Chang YS, Wang JP, Chen SC, Kuo SC. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med. 1998; 64: 153-8.
10. Goda Y, Kiuchi F, Shibuya M, Sankawa U. Inhibitors of prostaglandin biosynthesis from Dalbergia odorifera. Chem Pharm Bull. 1992; 40: 2452-7.
11. Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H, Okuyama T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 2004; 95: 448-53.
12. Kim JY, Park SJ, Yun KJ, Cho YW, Park HJ, Lee KT. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol. 2008; 584: 175-84.
13. Woo SW, Lee SH, Ko G, Kim YC, Sohn DH. Isoliquiritigenin Inhibits Cell Proliferation by a Heme Oxygenase-Dependent Pathway in Rat Hepatic Stellate Cells. Planta Med. 2008; 74: 834-9.
14. Namikoshi M, Nakata H, Nuno M, Ozawa T, Saitoh T. Homoisoflavonoids and related compounds. III. Phenolic constituents of Caesalpinia japonica SIEB. Et ZUCC. Chem Pharm Bull 1987; 35: 3568-75.
15. Kang TH, Tian YH, Kim YC. Isoliquiritigenin: A competitive tyrosine inhibitor from the heartwood of Dalbergia odorifera. J. Appl. Pharmacol. 2005; 13: 32-4.
16. Lee SH, Seo GS, Sohn DH. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochem. Biophys Res Commun. 2004; 323: 125-32.
17. Lee SH, Seo GS, Kim JY, Jin XY, Kim HD, Sohn DH. Heme oxygenase 1 mediates anti-inflammatory effects of 2′,4′,6′- tris(methoxymethoxy) chalcone. Eur J Pharmacol. 2006; 532: 178-86.
18. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol. 2001; 166: 4185-94.
19. Ban HS, Suzuki K, Lim SS, Jung SH, Lee S, Ji J, Lee HS, Lee YS, Shin KH, Ohuchi K. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2′- hydroxychalcone derivatives in RAW 264.7 cells. Biochem Pharmacol. 2004; 67: 1549-57.
20. Foresti R, Hoque M, Monti D, Green CJ, Motterlini R. Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J Pharmacol Exp Ther. 2005; 312: 686-93.
21. Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, Chin M, Onaya T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol. 1992; 212: 87-92.
22. Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of some natural products on the activation of hyaluronidase and their antiallergic actions. Chem Pharm. Bull. 1992; 40: 1439-42.
23. Alcaraz MJ, Vicente AM, Araico A, Dominguez JN, Terencio MC, Ferrándiz ML. Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells. Br J Pharmacol. 2004; 142: 1191-9.
24. Abuarqoub H, Foresti R, Green CJ, Motterlini R. Heme oxygenase-1 mediates the anti-inflammatory actions of 2′-hydroxychalcone in RAW 264.7 murine macrophages. Am. J Physiol Cell Physiol. 2006; 290: 1092-9.
25. Lee SH, Sohn DH, Jin XY, Kim SW, Choi SC, Seo GS. 2′,4′, 6′-tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-alpha-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways. Biochem Pharmacol. 2007; 74: 870-80.
26. Gong P, Cederbaum AI, Nieto N. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway. J Biol Chem. 2003; 278: 29693-700.
27. Gong P, Hu B, Cederbaum AI. Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch Biochem Biophys. 2004; 432: 252-60.
28. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radie Biol Med. 2005; 39: 355-64.